Literature DB >> 6839669

Platelet function and lipoprotein levels after plasma-exchange in patients with familial hypercholesterolaemia.

G Brook, G Winterstein, M Aviram.   

Abstract

1. Repeated plasma exchange was carried out on three young patients with severe familial hypercholesterolaemia. There was a 3 week interval between each exchange. After a single exchange, plasma cholesterol, apolipoprotein B and low density lipoprotein-cholesterol levels decreased markedly, but pre-exchange levels were not achieved within 2 weeks. High density lipoprotein-cholesterol and apolipoprotein A-I levels also fell but returned to the original concentration after only 5 days. 2. Platelet aggregation and [14C]serotonin release were increased in all three patients and dropped by 20% and 13% respectively after a single plasma exchange. Platelet function in vitro returned to pre-exchange levels with similar kinetics to that observed with the low density lipoprotein concentration. On removal of 100 g of plasma cholesterol, after repeated exchanges, low density lipoprotein concentration and platelet function were significantly decreased in comparison with values before initiation of plasma exchange. In addition there was a marked regression of xanthoma in all three patients. 3. Since this procedure is instrumental in achieving a negative cholesterol balance as well as inhibiting hypersensitive platelets, it may well result in a downgrading of the atherosclerotic risk.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6839669     DOI: 10.1042/cs0640637

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  7 in total

1.  Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.

Authors:  A Ugur Ural; M Ilker Yilmaz; Ferit Avcu; Atilla Yalcin
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Effect of trans fatty acids on plasma lipids, platelet function and systolic blood pressure in stroke-prone spontaneously hypertensive rats.

Authors:  M T Chiang; M I Otomo; H Itoh; Y Furukawa; S Kimura; H Fujimoto
Journal:  Lipids       Date:  1991-01       Impact factor: 1.880

3.  Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.

Authors:  S E Barrow; P D Stratton; N Benjamin; T Brassfield; J M Ritter
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

4.  Reduced plasma high-density lipoprotein and increased platelet activity in arterial versus venous blood.

Authors:  M Aviram; A Viener; J G Brook
Journal:  Postgrad Med J       Date:  1987-02       Impact factor: 2.401

5.  Chylomicron-like particles in severe hypertriglyceridemia.

Authors:  M Aviram; Y Sechter; J G Brook
Journal:  Lipids       Date:  1985-04       Impact factor: 1.880

6.  Differential effect of platelet inhibitors in normal and in hypercholesterolaemic subjects.

Authors:  M Aviram; G Winterstein; J G Brook
Journal:  Br J Clin Pharmacol       Date:  1985-06       Impact factor: 4.335

7.  Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects.

Authors:  A Markel; J G Brook; M Aviram
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.